Industry

AMR Action Fund
CARB-X
BEAM Alliance – EU BioPharma Companies
International Federation of Pharmaceutical Manufacturers & Associations – AMR
AMR Industry Alliance
Antimicrobial Resistance Benchmark

Microbide – Antimicrobial Biocide R&D (Dublin)
Westway Health – Biopharmaceutical (Galway)
Arann Technologies – Infection Control Company (Dublin)
Astellas Pharma – Anti-Infectives
Kastus Technologies – Infection Control Company (Dublin)
Mica NanoTech – Surface Coating Technologies (Limerick)
Iterum Therapeutics (Dublin Headquartered)
Nabriva Therapeutics (Dublin Headquartered)

Auspherix (UK)
Procarta Biosystems (UK)
Destinty Pharma (UK)
Cantab Anti-infectives (UK)

Evotec (Germany)
AiCuris (Germany)
Allecra Therapeutics (Germany)

Eligo Bioscience (France)
Mutabilis – Anti Infectives Company – (France)
Nosopharm (France)
Deinove (France)
Alaxia SAS (France)
Antabia (France)

ABAC Therapeutics (Spain)

Naicons (Italy)

Polyphor (Switzerland)
Bioversys (Switzerland)
Basilea (Switzerland)

SNIPR BIOME (Denmark)
Union Therapeutics (Denmark)

Northern Antibiotics (Finland)

Centrient Pharmaceuticals (NL)

Reece Pharmaceuticals (Australia)

Entasis Therapeutics (US)
Locus Biosciences (US)
Spero Therapeutics (US)
Venatorx Pharma (US)
Selux Diagnostics (US)
Vedanta Biosciences (US)
Amplyx Pharmaceuticals (US)
Cidara Therapeutics (US)
Paratek Pharma (US)
Nabriva Therapeutics (US – HQ in Ireland)
Amicrobe Inc (US)
Armata Pharmaceuticals (US)
Aridis Pharmaceuticals (US)
SCYNEXIS Inc (US)
Peptilogics (US)
Crestone Pharma (US)

Bugworks (India)